Vascular Pharmacology

Papers
(The median citation count of Vascular Pharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study65
Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors65
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage61
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells59
Endothelial cells and SARS-CoV-2: An intimate relationship45
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection40
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies35
Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis30
Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis27
Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress26
Perivascular adipose-derived exosomes reduce macrophage foam cell formation through miR-382-5p and the BMP4-PPARγ-ABCA1/ABCG1 pathways25
Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p/IGF2 axis23
A possible role for ST2 as prognostic biomarker for COVID-1921
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications20
Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis19
Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome19
Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation18
Diabetic neuropathy: Molecular approach a treatment opportunity18
Extracellular vesicles (EVs) in ischemic conditioning and angiogenesis: Focus on endothelial derived EVs18
Angiotensin-II activates vascular inflammasome and induces vascular damage17
Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ti16
Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis16
Effects of statins in primary and secondary prevention for venous thromboembolism events: A meta analysis15
Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment15
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency15
Estrogen increases expression of vascular alpha 2C adrenoceptor through the cAMP/Epac/JNK/AP-1 pathway and potentiates cold-induced vasoconstriction15
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism15
Exploring the regulatory roles of circular RNAs in the pathogenesis of atherosclerosis14
Extracellular vesicle-mediated miR135a-5p transfer in hypertensive rat contributes to vascular smooth muscle cell proliferation via targeting FNDC514
Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients13
Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair13
Increased histone-DNA complexes and endothelial-dependent thrombin generation in severe COVID-1913
Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration13
Circ_0004872 promotes platelet-derived growth factor-BB-induced proliferation, migration and dedifferentiation in HA-VSMCs via miR-513a-5p/TXNIP axis13
Loss of Jagged1 in mature endothelial cells causes vascular dysfunction with alterations in smooth muscle phenotypes13
Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy12
Maslinic acid suppresses macrophage foam cells formation: Regulation of monocyte recruitment and macrophage lipids homeostasis12
Non-coding RNAs regulate angiogenic processes12
MCU-dependent mitochondrial calcium uptake-induced mitophagy contributes to apelin-13-stimulated VSMCs proliferation12
Effect of high-dose statin therapy on coagulation factors: Lowering of factor XI as a modifier of fibrin clot properties in coronary artery disease12
Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment12
The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p–MEF2A–ET-1 axis11
Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles11
Tissue optical clearing for 3D visualization of vascular networks: A review11
Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection11
New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis11
Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients11
The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies10
Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction10
Ischemic heart disease and cardioprotection: Focus on estrogenic hormonal setting and microvascular health10
4-hydroxy-2-nonenal decreases coronary endothelial cell migration: Potentiation by aldehyde dehydrogenase 2 inhibition10
Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk10
Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes9
CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells9
Arg mediates LPS-induced disruption of the pulmonary endothelial barrier9
Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro9
Tetrandrine promotes angiogenesis via transcriptional regulation of VEGF-A9
Differential expression of microRNA and arachidonic acid metabolism in aspirin-treated human cardiac and peri-cardiac fat-derived mesenchymal stem cells9
The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-κB signaling9
Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses9
Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells9
Septic shock as a trigger of arterial stress-induced premature senescence: A new pathway involved in the post sepsis long-term cardiovascular complications9
Vildagliptin improves vascular smooth muscle relaxation and decreases cellular senescence in the aorta of doxorubicin-treated rats9
Beneficial effects of melatonin on prostanoids pathways in pulmonary hypertensive neonates8
Osteogenic differentiation and calcification of human aortic smooth muscle cells is induced by the RCN2/STAT3/miR-155-5p feedback loop8
Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves8
Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation8
Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein8
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E–deficient mice8
Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats8
The lncRNA PAHRF functions as a competing endogenous RNA to regulate MST1 expression by sponging miR-23a-3p in pulmonary arterial hypertension8
High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?8
Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: Novel targets for therapy8
Optical excitation of organic semiconductors as a highly selective strategy to induce vascular regeneration and tissue repair8
Targeting endothelial ion signalling to rescue cerebral blood flow in cerebral disorders8
Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dement7
Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning7
Hdac9 inhibits medial artery calcification through down-regulation of Osterix7
Chronic cyclooxygenase-2 inhibition prevents the worsening of hypertension and endothelial dysfunction induced by ouabain in resistance arteries of spontaneously hypertensive rats7
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention7
Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endoth7
Thromboprophylaxis strategies to improve the prognosis of COVID-197
Effects of edoxaban and warfarin on vascular remodeling: Atherosclerotic plaque progression and collateral artery growth7
Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?7
The potential role of thymoquinone in preventing the cardiovascular complications of COVID-197
Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke7
Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomiz7
In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity7
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment7
MARCKS mediates vascular contractility through regulating interactions between voltage-gated Ca2+ channels and PIP26
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: a meta-analysis6
Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability6
Inducible degrader of LDLR: A potential novel therapeutic target and emerging treatment for hyperlipidemia6
Angiocrine endothelium: From physiology to atherosclerosis and cardiac repair6
Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching6
The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project6
Exploring the mechanisms of action of gliflozines in heart failure and possible implications in pulmonary hypertension6
Targeting androgen receptor in macrophages inhibits phosphate-induced vascular smooth muscle cell calcification by decreasing IL-6 expression6
Influence of long-term proteasome inhibition on platelet responsiveness mediated by bortezomib5
Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolism5
COMP-Ang1: Therapeutic potential of an engineered Angiopoietin-1 variant5
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity5
Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease5
Late phase endothelial cell inflammation is characterized by interferon response genes and driven by JAK/STAT, not NFκB5
Brain-derived neurotrophic factor is a full endothelium-derived factor in rats5
The close link between brain vascular pathological conditions and neurodegenerative diseases: Focus on some examples and potential treatments5
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro5
Kidney endothelial cell heterogeneity, angiocrine activity and paracrine regulatory mechanisms4
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact4
The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate4
Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects4
A review of genetically-driven rodent models of pulmonary hypertension4
Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification4
SGLT2-i prevent left ventricular dysfunction induced by anthracycline in mouse model: A systematic-review and meta-analysis4
Hinokitiol produces vasodilation in aortae from normal and angiotensin II- induced hypertensive rats via endothelial-dependent and independent pathways4
Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction4
Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials4
Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents4
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus4
TLR4-Myd88 pathway upregulated caveolin-1 expression contributes to coronary artery spasm4
Exercise-induced pulmonary hypertension in HIV patients: Association with poor clinical and immunological status4
Endothelial TrkB receptor activation controls vascular tone of rat middle cerebral artery4
Platelet apelin receptor expression is reduced in patients with acute myocardial infarction4
G6PD is a critical enabler of hypoxia-induced accumulation of macrophages and platelets in mice lungs and contributor to lung inflammation4
Insulin-treated versus noninsulin-treated diabetes and risk of ischemic stroke in patients with atrial fibrillation4
Glucocorticoid induced TNF receptor family-related protein (GITR) – A novel driver of atherosclerosis3
CRH/CRHR1 modulates cerebrovascular endothelial cell permeability in association with S1PR2 and S1PR3 under oxidative stress3
NAD+ attenuates cardiac injury after myocardial infarction in diabetic mice through regulating alternative splicing of VEGF in macrophages3
Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside3
Methylglyoxal-induced miR-223 suppresses rat vascular KATP channel activity by downregulating Kir6.1 mRNA in carbonyl stress3
17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis3
Midkine mediates dysfunction of liver sinusoidal endothelial cells through integrin α4 and α63
Interaction of ACEI antihypertensive agent's administration with the inflammatory status at admission concerning COVID-19 clinical stay outcomes3
A simple and accurate method to quantify real-time contraction of vascular smooth muscle cell in vitro3
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease3
Melatonin treatment during chronic hypoxic gestation improves neonatal cerebrovascular function3
Berberine inhibits osteogenic differentiation of aortic valve interstitial cells by interfering Smad1/5/8 and NF-κB pathways3
Amyloid-β: A potential mediator of aging-related vascular pathologies3
Mediterranean G6PD variant rats are protected from Angiotensin II-induced hypertension and kidney damage, but not from inflammation and arterial stiffness3
COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3?3
TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats3
Glyphosate-induced injury in neurons, endothelial cells and myoblasts is mediated by ROS production3
Targeting residual inflammatory risk: The next frontier for atherosclerosis treatment and prevention3
Beta-blockers in pulmonary arterial hypertension: Time for a second thought?3
The changing landscape of the vulnerable plaque: a call for fine-tuning of preclinical models3
Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice3
Sphingosine 1-phosphate-induced nitric oxide production simultaneously controls endothelial barrier function and vascular tone in resistance arteries3
Prenatal exercise reprograms the development of hypertension progress and improves vascular health in SHR offspring3
Inflammation and the pathogenesis of atherosclerosis3
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice3
Sdox, a H2S releasing anthracycline, with a safer profile than doxorubicin toward vasculature3
Anticoagulation therapy in patients with post-operative atrial fibrillation: Systematic review with meta-analysis2
RNA sequencing identifies genes reliant upon Ser26 in the zinc finger transcription factor, early growth response-12
MRTFA overexpression promotes conversion of human coronary artery smooth muscle cells into lipid-laden foam cells2
Systematic analysis of different pluripotent stem cell-derived cardiac myocytes as potential testing model for cardiocytoprotection2
The recent applications of nanotechnology in the diagnosis and treatment of common cardiovascular diseases2
DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arteries2
The non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with high-normal renal function – A systematic review2
Potency of miR-144-3p in promoting abdominal aortic aneurysm progression in mice correlates with apoptosis of smooth muscle cells2
Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection2
Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension2
Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties2
Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries2
Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk2
Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health2
Comparative efficacy of fixed-dose statin and antihypertensive agent combinations: A network meta-analysis of randomized controlled trials2
Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients2
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)2
The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis2
Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension2
Quinazoline-based human phosphodiesterase 5 inhibitors exhibited a selective vasorelaxant effect on rat isolated pulmonary arteries involving NO-sGC-cGMP pathway and calcium inhibitory effects2
Insights into elastic fiber fragmentation: Mechanisms and treatment of aortic aneurysm in Marfan syndrome2
SC1 limits tube formation, branching, migration, expansion and induce apoptosis of endothelial cells2
Factors influencing the soluble guanylate cyclase heme redox state in blood vessels2
Eighty years of oral anticoagulation: Learning from history2
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions2
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention1
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease1
Antineoplastic drugs inducing cardiac and vascular toxicity – An update1
Involvement of HIF1α/Reg protein in the regulation of HMGB3 in myocardial infarction1
Intrinsic exercise capacity induces divergent vascular plasticity via arachidonic acid-mediated inflammatory pathways in female rats1
Mitochondrial dynamics and cardiac response to hypoxia in the goldfish Carassius auratus1
Quantitative and structural characteristics of mitochondrial DNA in varicose veins1
Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients1
Sacubitril/valsartan effects on arrhythmias and left ventricular remodelling in heart failure: An observational study1
Pathophysiology of coronary microvascular dysfunction1
Differential effects of cyclooxygenase-2 (COX-2) inhibitors on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells1
Hypertension, coronary artery disease and myocardial ischemic syndromes1
Emerging therapies in dyslipidaemias1
Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: Focus on coronary modulators1
The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium – Possible consequences fo1
Trimethylamine N-oxide (TMAO) effects on isolated adult rat cardiomyocytes1
Animal experimental models of ischemic limbs – A systematic review1
Endothelial heterogeneity and their relevance in cardiac development and coronary artery disease1
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology1
The crosstalk between osteodifferentiating stem cells and endothelial cells promotes angiogenesis and bone formation1
Pulmonary artery pressure-directed therapies in pulmonary arterial hypertension?1
Impact of high on-treatment platelet reactivity after angioplasty in patients with critical limb ischemia1
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors1
Small extracellular vesicles from pregnant women with maternal supraphysiological hypercholesterolemia impair endothelial cell function in vitro1
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity1
Deleterious effects of levamisole, a cocaine adulterant, in rabbit aorta1
Cardiovascular aspects of ELABELA: A potential diagnostic biomarker and therapeutic target1
Exploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of disease1
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes1
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trials1
Potential efficacy of L-arginine supplementation in the treatment of fabry cardiomyopathy by recovering mitochondrial function1
Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy1
GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid1
Sodium nitroprusside for advanced heart failure. A metanalysis of literature data1
Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches1
Biobanks: The unmet need in heart failure management1
Imbalance of calcium-dependent mechanisms in cardiac mesenchymal stromal cells from arrhythmogenic cardiomyopathy patients1
Direct oral anticoagulants versus vitamin-K antagonists in patients with left ventricular thrombus: A systematic review and meta-analysis1
Heterogeneous vasomotor responses in segments from Göttingen Minipigs coronary, cerebral, and mesenteric artery: A comparative study1
miR-10b promotes aortic aneurysm formation and aortic rupture in angiotensin II-induced ApoE-deficient mice1
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension1
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function1
Angiogenesis is promoted by hypoxic cervical carcinoma-derived extracellular vesicles depending on the endothelial cell environment1
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets1
Biomechanical stretch-induced CLOCK upregulation in venous smooth muscle cells promotes phenotypic and functional transformation1
Interaction of FOXO1 and SUMOylated PPARγ1 induced by hyperlipidemia and hyperglycemia favors vascular endothelial insulin resistance and dysfunction1
Corrigendum to “Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis” [Vascul. Pharmacol. 101(2018) 29–37]1
Long-acting opioids and cardiovascular diseases: Help or hindrance!1
Association of antihypertensive drugs with psoriasis: A trans-ancestry and drug-target Mendelian randomization study0
Contents continued0
Graphical abstract TOC0
Editorial Board0
Editorial Board0
Editorial Board0
Editorial Board0
Iron protein Tfr2 is not involved in hypoxia dependent hepatic Hepcidin regulation: What about the heart?0
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study0
A critical appreciation of pathway analysis in atherosclerotic disease. Cellular phenotypic plasticity as an illustrative example0
Graphical abstract TOC0
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease0
Graphical abstract TOC0
Editorial Board0
Graphical abstract TOC0
The role of gluconeogenesis in the goldfish heart response to hypoxia: An MS-based proteomic analysis0
Is remote conditioning cardioprotection temperature dependent?0
Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??0
Graphical abstract TOC0
Editorial Board0
Contents continued0
Graphical abstract TOC0
Risk assessment in Scleroderma-associated pulmonary arterial hypertension0
Flux-independent NMDA receptors induce Ca2+-dependent nitric oxide release from human brain microvascular endothelial cells0
The functional expression of the Lamin A/C mutant Q517X in HL1 cardiomyocytes causes nuclear and cytoskeleton remodeling with reduction in spontaneous action potentials frequency0
Graphical abstract TOC0
0.035933971405029